Antibiotic Market’s Growth to Ride on Newer Product Formulations as Microbial Resistance Necessitates Advancement

Transparency Market Research (TMR) presents a new market study, titled “Antibiotic Market - Global Industry Size, Share, Trends, Analysis And Forecast 2012 – 2018”, in which the proceedings of the global antibiotic market are analyzed across North America, Asia Pacific, Europe, and Rest of the World (RoW).

The report is a useful tool for pin-point analysis of the changing dynamics of the antibiotic market for the seven-year forecast period from 2012 to 2018. It extends a forward-looking outlook to present the various factors driving or restraining the market’s growth. The antibiotic market is also analyzed from a technological viewpoint, which helps readers understand the corresponding product development in the due course.

According to the report findings, the global antibiotic market will be advancing rapidly during the forecast period thanks to new product development and substantial funding for R&D supporting growth of the same. The development of generic drugs, which claim to be at par with original formulations for efficacy, is slated to be another major factor aiding the development of the antibiotic market.

Other than this, medical treatment malpractices due to lack of education and unawareness among consumers have been a reason for the uncontrolled use of antibiotics, which has resulted in microbial resistance against antibiotics. This has necessitated the development of alternate antibiotic formulations to overcome these issues.

Get Free PDF Brochure for more Professional and Technical industry insights: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=590

In this context, the antibacterial drugs market is expected to witness sluggish growth due to focus of drug manufacturers on developing formulations against staph infections such as methicillin-resistant Staphylococcus aureus (MRSA) and patent expiration of the key manufacturers. Thus, new drugs will emerge in the market consequently.

In matters of development, historical figures indicate that the antibiotic market has been progressing steadily hitherto. With an annual growth rate of 6.6% between 2005 and 2011, high incidence of bacterial infections due to the emergence of newer bacterial variants has been the reason for the antibiotic market to be consistently rising. In this regard, in the near future, the demand for antibiotics will be on the rise and is expected to be worth US$44.68 bn by 2016.

The report lists some of the major companies operating in the global antibiotic market with their detailed business profiles. These include Bayer Healthcare AG, Astellas Pharma Inc., Abbott Laboratories, Daiichi Sankyo Company Limited, Takeda Pharmaceutical Company Ltd., GlaxoSmithKline Plc., Johnson & Johnson, LG Life Sciences Limited Inc., Pliva d.d., Toyama Chemical Co. Ltd., Roche, Bristol-Myers Squibb Co., MiddleBrook Pharmaceuticals, Sankyo Company Limited, Cubist Pharmaceuticals Inc., Eli Lilly and Co., Kyorin Pharmaceutical Co. Ltd., Pfizer Inc., Novartis AG, and Sanofi-Aventis SA.

Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.